Valuation Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
12:07:18 22/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2,777.30 INR | +0.75% |
|
+0.81% | +51.10% |
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 08-12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Company Valuation: Caplin Point Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 51,529 | 45,291 | 100,038 | 152,221 | 114,409 | 211,259 | - |
| Change | - | -12.11% | 120.88% | 52.16% | -24.84% | 84.65% | - |
| Enterprise Value (EV) | 51,529 | 45,291 | 100,038 | 152,221 | 114,409 | 211,259 | 211,259 |
| Change | - | -12.11% | 120.88% | 52.16% | -24.84% | 84.65% | 0% |
| P/E | 17.3x | 12.1x | 22x | 28.5x | 17.9x | 29.1x | 25.1x |
| PBR | 3.47x | 2.41x | 4.32x | 5.34x | 3.19x | 4.78x | 4.32x |
| PEG | - | 0.5x | 1x | 1.6x | 0.9x | 2.1x | 1.6x |
| Capitalization / Revenue | 4.06x | 3.09x | 5.91x | 7.86x | 5.23x | 8.43x | 7.45x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 8.43x | 7.45x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 24.3x | 21x |
| EV / EBIT | 0x | 0x | - | 0x | 0x | 22.7x | 19.6x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 38x | 37.4x |
| FCF Yield | 4.77% | 1.72% | 1.73% | 1.58% | 2.4% | 2.63% | 2.67% |
| Dividend per Share 2 | 2 | 2 | 2.5 | 3 | - | 4 | 4 |
| Rate of return | 0.29% | 0.34% | 0.19% | 0.15% | - | 0.14% | 0.14% |
| EPS 2 | 39.26 | 49.18 | 59.9 | 70.25 | 84.11 | 95.6 | 110.7 |
| Distribution rate | 5.09% | 4.07% | 4.17% | 4.27% | - | 4.18% | 3.61% |
| Net sales 1 | 12,694 | 14,667 | 16,941 | 19,375 | 21,872 | 25,072 | 28,340 |
| EBITDA 1 | 3,947 | 4,411 | 5,514 | 6,469 | 7,609 | 8,700 | 10,050 |
| EBIT 1 | 3,478 | 4,520 | - | 5,810 | 8,036 | 9,321 | 10,752 |
| Net income 1 | 2,998 | 3,763 | 4,571 | 5,363 | 6,412 | 7,264 | 8,411 |
| Net Debt | - | - | - | - | - | - | - |
| Reference price 2 | 679.90 | 596.70 | 1,317.30 | 2,002.60 | 1,505.15 | 2,779.30 | 2,779.30 |
| Nbr of stocks (in thousands) | 75,789 | 75,903 | 75,942 | 76,012 | 76,012 | 76,012 | - |
| Announcement Date | 12/05/22 | 27/05/23 | 16/05/24 | 15/05/25 | 14/05/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 34.48x | 6.47x | 22.44x | 0.91% | 46.81B | |
| 15.9x | 1.97x | 8.74x | 1.7% | 37.1B | |
| 27.84x | 3.97x | 16.45x | 0.58% | 12.09B | |
| 26.98x | 3.27x | 16.95x | 0.94% | 11.69B | |
| 18.58x | 3.37x | 11.75x | 3.79% | 9.03B | |
| 9.49x | 2.2x | 5.69x | 4.68% | 7.45B | |
| 29.8x | 3.9x | 18.14x | 0.16% | 7.22B | |
| 15.18x | 2.01x | 6.67x | 3.28% | 7.13B | |
| Average | 22.28x | 3.39x | 13.35x | 2% | 17.31B | |
| Weighted average by Cap. | 24.67x | 3.98x | 15.15x | 1.57% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CAPLIPOINT Stock
- CAPLIPOINT Stock
- Valuation Caplin Point Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
